{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:46:30Z","timestamp":1791254790803,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"F Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.msard.2022.104245","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T11:47:17Z","timestamp":1666007237000},"page":"104245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study"],"prefix":"10.1016","volume":"68","author":[{"given":"Rachel","family":"Knapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e4nce","family":"Hardtstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Maywald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Chognot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Muros-Le Rouzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8841-8035","authenticated-orcid":false,"given":"Licinio","family":"Craveiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2022.104245_bib0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.msard.2022.104245_bib0002","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2022.104245_bib0003","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1352458520910497","article-title":"Comorbid disease burden among MS patients 1968\u20132012: a Swedish register\u2013based cohort study","volume":"27","author":"Smith","year":"2020","journal-title":"Mult. Scler."},{"issue":"24","key":"10.1016\/j.msard.2022.104245_bib0004","doi-asserted-by":"crossref","first-page":"e2216","DOI":"10.1212\/WNL.0000000000008617","article-title":"Disability worsening among persons with multiple sclerosis and depression","volume":"93","author":"Binzer","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2022.104245_bib0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ane.13516","article-title":"Impact of comorbidities on the disability progression in multiple sclerosis","volume":"145","author":"Maric","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2022.104245_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102420","article-title":"Infections in patients with multiple sclerosis: a national cohort study in Sweden","volume":"45","author":"Castelo-Branco","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.msard.2022.104245_bib0007","first-page":"1153","article-title":"Hospital admission due to infections in multiple sclerosis patients","volume":"20","author":"Montgomery","year":"2013","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2022.104245_bib0008","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7224\/1537-2073.2014-035","article-title":"Multiple Sclerosis and Risk of Infection-Related Hospitalization and Death in US Veterans","volume":"17","author":"Nelson","year":"2015","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.msard.2022.104245_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101982","article-title":"Infections in patients diagnosed with multiple sclerosis: a multi-database study","volume":"41","author":"Persson","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"11","key":"10.1016\/j.msard.2022.104245_bib0010","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1177\/1352458516681198","article-title":"Infection-related health care utilization among people with and without multiple sclerosis","volume":"23","author":"Wijnands","year":"2017","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.msard.2022.104245_bib0011","doi-asserted-by":"crossref","first-page":"e820","DOI":"10.1212\/WNL.0000000000008907","article-title":"Multiple cause of death analysis in multiple sclerosis","volume":"94","author":"Harding","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2022.104245_bib0012","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000504804","article-title":"Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: a Population-Based Study","volume":"54","author":"Kingwell","year":"2020","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.msard.2022.104245_bib0013","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/jamaneurol.2019.3365","article-title":"Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies","volume":"77","author":"Luna","year":"2020","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.msard.2022.104245_bib0014","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/1744666X.2021.1886924","article-title":"Assessing and mitigating risk of infection in patients with multiple sclerosis on disease modifying treatment","volume":"17","author":"Otero-Romero","year":"2021","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.msard.2022.104245_bib0015","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jnnp-2017-317493","article-title":"Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study","volume":"89","author":"Wijnands","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.msard.2022.104245_bib0016","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.msard.2022.104245_bib0017","article-title":"Risk of serious infections in multiple sclerosis patients by disease course and disability status: results from a Swedish register-based study","volume":"22","author":"Brand","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"issue":"4","key":"10.1016\/j.msard.2022.104245_bib0018","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/intqhc\/mzv045","article-title":"Are administrative data valid when measuring patient safety in hospitals? A comparison of data collection methods using a chart review and administrative data","volume":"27","author":"Maass","year":"2015","journal-title":"Int. J. Qual. Health Care"},{"issue":"12","key":"10.1016\/j.msard.2022.104245_bib0019","doi-asserted-by":"crossref","DOI":"10.1097\/MLR.0b013e3181ef9d3e","article-title":"The Development, Evolution, and Modifications of ICD-10: challenges to the International Comparability of Morbidity Data","volume":"48","author":"Jett\u00e9","year":"2010","journal-title":"Med. Care"},{"issue":"4","key":"10.1016\/j.msard.2022.104245_bib0020","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","article-title":"Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database","volume":"43","author":"Quan","year":"2008","journal-title":"Health Serv. Res."},{"issue":"9","key":"10.1016\/j.msard.2022.104245_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257183","article-title":"Transforming the German ICD-10 (ICD-10-GM) into Injury Severity Score (ISS)\u2014Introducing a new method for automated re-coding","volume":"16","author":"Niemann","year":"2021","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.msard.2022.104245_bib0022","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1352458516633903","article-title":"Urinary tract infections in multiple sclerosis","volume":"22","author":"Ph\u00e9","year":"2016","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2022.104245_bib0023","first-page":"57","article-title":"Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital","volume":"3","author":"Mahadeva","year":"2014","journal-title":"Am. J. Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2022.104245_bib0024","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000119641","article-title":"Cough Efficacy Is Related to the Disability Status in Patients with Multiple Sclerosis","volume":"76","author":"Aiello","year":"2008","journal-title":"Respiration"},{"issue":"6","key":"10.1016\/j.msard.2022.104245_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122686","article-title":"Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS","volume":"10","author":"Ribbons","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.msard.2022.104245_bib0026","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/jnnp-2012-304333","article-title":"Onset of secondary progressive phase and long-term evolution of multiple sclerosis","volume":"85","author":"Scalfari","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.msard.2022.104245_bib0028","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41582-019-0183-3","article-title":"Epidemiology and treatment of multiple sclerosis in elderly populations","volume":"15","author":"Vaughn","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2022.104245_bib0027","unstructured":"Holstiege, J., Steffen, A., Goffrier, B., B\u00e4tzing, J., 2017. Epidemiology of multiple sclerosis \u2013 a population-based, Germany-wide study. Central Research Institute of Ambulatory Health Care in Germany (Zi). Versorgungsatlas Report No. 17\/09. Berlin, 2017. DOI: 10.20364\/VA-17.09. URL: http:\/\/www.versorgungsatlas.de\/themen\/alle-analysen-nach-datum-sortiert\/?tab=6&uid=86."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822007490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822007490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:04:07Z","timestamp":1761901447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822007490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":28,"alternative-id":["S2211034822007490"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.104245","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.104245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104245"}}